瑞舒伐他汀在动脉粥样硬化中抗炎机制的研究进展  

The research progress of Rosuvastatin in the anti-inflammatory mechanism of the sclerosis of arterial congee appearance

作　　者：施铁 赵兴胜[1] 

机构地区：[1]内蒙古医科大学,内蒙古呼和浩特010020

出　　处：《医药前沿》2016年第9期6-7,共2页Journal of Frontiers of Medicine

基　　金：（苏州市科技局立项资助项目SYS201258,江苏省中医药局立项资助项目LZ13147）

摘　　要：目的：综述瑞舒伐他汀在动脉粥样硬化中抗炎机制的研究进展。方法：采用文献综述法对国内外相关瑞舒伐他汀在动脉粥样硬化中抗炎机制的研究文献进行综合性分析，从而分析炎性与动脉粥样硬化的关系，综合阐述瑞舒伐他汀抗炎机制。结果：炎症反应主要是由于斑块不稳定、巨噬细胞等造成的。结论：瑞舒伐他汀能够改善患者的炎症反应，形成抗血栓作用，从而改善患者疾病的不稳定性，应进一步加强对瑞舒伐他汀治疗动脉粥样硬化患者的临床研究。Objective To review Rosuvastatin in the study of the anti-inflammatory mechanism of the sclerosis of arterial congee appearance. Methods Using literature review method, comprehensive analysis of relevant research literature at home and abroad, the comprehensive elaboration, Rosuvastatin anti-inflammatory mechanism. Results The inflammatory response is mainly caused by unstable plaque, macrophages, etc. Conclusion Rosuvastatin can improve the patient＇s inflammation, forming the antithrombotic effects. Therefore, we should further strengthen to Rosuvastatin clinical research.

关 键 词：动脉粥样硬化 抗炎机制 瑞舒伐他汀 

分 类 号：R543[医药卫生—心血管疾病]